Direxion Daily S&P Biotech Bull 3x Shares (LABU)
|Ex-Dividend Date||Dec 23, 2019|
|Day's Range||50.00 - 52.86|
|Inception Date||May 28, 2015|
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index (index). The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds (ETFs) that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS). The fund is non-diversified.
Top 10 Holdings77.26% of assets
|S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP||N/A||22.31%|
|S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP||N/A||19.24%|
|S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP||N/A||17.66%|
|S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP||N/A||6.24%|
|GOLDMAN FINL SQ TRSRY INST 506||N/A||3.65%|
|S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAP||N/A||2.63%|
|DREYFUS GOVT CASH MGMT||N/A||2.21%|
|DREYFUS GOVT CASH MGMT||N/A||1.94%|
|DREYFUS GOVT CASH MGMT||N/A||0.75%|
|GOLDMAN FINL SQ TRSRY INS||N/A||0.63%|
|Dec 23, 2019||$0.00531||Dec 31, 2019|
|Sep 24, 2019||$0.01084||Oct 1, 2019|
|Jun 25, 2019||$0.03745||Jul 2, 2019|
|Mar 19, 2019||$0.10973||Mar 26, 2019|
|Dec 27, 2018||$0.09621||Jan 4, 2019|
|Sep 25, 2018||$0.0954||Oct 2, 2018|
The biotechnology sector has been on fire thanks to news from Biogen Inc. (NASDAQ: BIIB). The FDA approved its controverisal drug that can treat Alzheimer's Disease.
Direxion's weekly ETF fund flows could shed light on what traders are thinking. The top three point to interest in long-term bond prices, biotech strength, and semiconductor weakness.
U.S. president Joe Biden's infrastructure plan is opening up ETF trading possibilities from multiple angles. One way is playing its healthcare component via funds like the Direxion Daily Healthcare Bull...
The biotechnology industry isn't backing down, with ETFs like the Direxion Daily S&P Biotech Bull 3x Shares (LABU) gaining over 15% to start the new year. More strength could be ahead as the global econ...
We highlight some leveraged ETFs that gained more than 85% over the past three months.
Traders understand that when you add leverage to the mix, the results can be explosive gains, but on the flip side, it could be losses and a blown trading account. Yahoo Finance focused on top leveraged...
This year has witnessed historic twists and turns with the largest bull market turning into a bear market in March on the coronavirus outbreak, and then marking the fastest-ever recovery.
The S&P 500, the Dow Jones and the Nasdaq Composite gained about 1.7%, 1.0% and 2.1%, respectively, last week.
The solid fundamentals and a soaring stock market have resulted in huge demand for the leveraged ETFs.